Amalgamated Bank lowered its position in Encompass Health Co. (NYSE:EHC – Get Rating) by 1.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 71,754 shares of the company’s stock after selling 968 shares during the period. Amalgamated Bank owned approximately 0.07% of Encompass Health worth $5,102,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Meeder Asset Management Inc. purchased a new stake in Encompass Health during the 1st quarter worth approximately $33,000. Worth Asset Management LLC purchased a new stake in Encompass Health during the 1st quarter worth approximately $35,000. Covestor Ltd purchased a new stake in Encompass Health during the 4th quarter worth approximately $38,000. Allworth Financial LP grew its position in Encompass Health by 83.1% during the 1st quarter. Allworth Financial LP now owns 630 shares of the company’s stock worth $45,000 after purchasing an additional 286 shares during the last quarter. Finally, Rather & Kittrell Inc. purchased a new stake in Encompass Health during the 4th quarter worth approximately $49,000. Hedge funds and other institutional investors own 93.07% of the company’s stock.
Encompass Health Stock Performance
EHC opened at $51.32 on Tuesday. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.24 and a quick ratio of 1.24. The firm has a fifty day moving average price of $50.73 and a 200 day moving average price of $59.44. Encompass Health Co. has a 1 year low of $44.33 and a 1 year high of $78.31. The stock has a market cap of $5.12 billion, a P/E ratio of 15.69, a P/E/G ratio of 2.41 and a beta of 1.02.
Encompass Health Cuts Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health’s dividend payout ratio is presently 34.25%.
Analyst Ratings Changes
Several analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Encompass Health from $80.00 to $62.00 in a research report on Wednesday, August 3rd. TheStreet cut shares of Encompass Health from a “b-” rating to a “c+” rating in a research note on Tuesday, June 28th. Barclays decreased their price objective on shares of Encompass Health from $80.00 to $63.00 and set an “overweight” rating for the company in a research note on Thursday, August 4th. Royal Bank of Canada decreased their price objective on shares of Encompass Health from $82.00 to $66.00 in a research note on Wednesday, August 24th. Finally, Stephens decreased their price objective on shares of Encompass Health from $78.00 to $74.00 and set an “overweight” rating for the company in a research note on Tuesday, June 21st. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Encompass Health has a consensus rating of “Buy” and a consensus target price of $70.10.
Insiders Place Their Bets
In other Encompass Health news, CEO Mark J. Tarr sold 20,449 shares of the company’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $53.25, for a total transaction of $1,088,909.25. Following the completion of the transaction, the chief executive officer now directly owns 440,895 shares in the company, valued at $23,477,658.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.70% of the stock is currently owned by company insiders.
Encompass Health Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.